Eikon Therapeutics Inc. is a clinical-stage biotechnology company dedicated to revolutionizing drug discovery through the application of super-resolution microscopy and advanced engineering. Founded by a team including Nobel laureate Eric Betzig, the company utilizes a proprietary platform that tracks the movement of individual protein molecules in living cells. This 'Single-Molecule Tracking' (SMT) technology allows researchers to observe the dynamic behavior of proteins in real-time, providing unique insights into disease mechanisms and potential therapeutic targets that were previously inaccessible. Eikon's approach integrates high-throughput imaging, machine learning, and sophisticated software to analyze massive datasets, enabling the identification of novel drug candidates with high precision. The company's pipeline targets a range of therapeutic areas, including oncology, immunology, and neurodegeneration. By combining physics, biology, and engineering, Eikon aims to accelerate the drug discovery process and bring life-changing medicines to patients with high unmet medical needs.
How many years of EBITDA are required to pay off the company's net debt, according to the official accounting standard IFRS16. As a market consensus, a value of up to 3 years of leverage is accepted for most companies.
How much the company's debt represents in % in relation to its equity. As a market consensus, a value less than or equal to 1 is accepted, above that leverage can end up hurting the final result at some point.
The current ratio helps investors understand more about a company's ability to cover its short-term debt with its current assets and make apples-to-apples comparisons with its competitors and peers.
The quick ratio measures a company's capacity to pay its current liabilities without needing to sell its inventory or obtain additional financing and is considered a more conservative measure than the current ratio, which includes all current assets as coverage for current liabilities.
The interest coverage ratio is used to measure how well a firm can pay the interest due on outstanding debt and is is calculated by dividing a company's earnings before interest and taxes (EBIT) by its interest expense during a given period. Generally, a higher coverage ratio is better, although the ideal ratio may vary by industry.
...and much more!